Sponsored Links
| Neuralstem Receives FDA Approval To Commence Drug Trial For Major Depression |
 |
 |
 |
| Medical News - Depression | |||
|
Neuralstem, Inc. (NYSE Amex: CUR) announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression... Read more: Depression News From Medical News Today
|